Stock Events

Stock Events

Oncolys BioPharma (4588.TSE) Q3 2025 Earnings

8AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-32

-27

-22

-17

Details

Expected EPS

N/A

Actual EPS

-21

Surprise EPS

-21

Surprise Percent

+∞%

Description

Oncolys BioPharma (4588.TSE) has reported earnings of -21 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.